Generic Lidocaine Patch Would Not Infringe Appellants’ Patents, Federal Circuit Agrees
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on Aug. 4 affirmed a Florida federal judge’s final judgment of noninfringement in a patent dispute over a generic lidocaine...To view the full article, register now.
Already a subscriber? Click here to view full article